BeyondSpring Inc.
BYSI Nasdaq· Pharmaceutical Preparations
Last close · Oct 26, 2026
$0.46
KIRA · Stoqly’s AI analyst, in plain words
- BeyondSpring Inc. had $0.0M of revenue in fiscal 2025.
- BeyondSpring Inc. lost $1.0M in fiscal 2025.
- Free cash flow was −$19.8M in fiscal 2025, — of revenue.
Market cap
—
P/E
—
Revenue
$0.0M
Net income
−$1.0M
Free cash flow
−$19.8M
Operating margin
—
BeyondSpring Inc. in 30 seconds · fiscal 2025
Does it make a profit?
−$1.0M
No. It lost money last year.
What BeyondSpring Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 25, 2026
- Legal name
- BeyondSpring Inc.
- CIK
- 0001677940
BeyondSpring Inc. · BYSI
Results and finances
The last 3 fiscal years. Amounts in USD.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Sales and profit | |||
| Revenue | $0.0M | $0.0M | $0.0M |
| Net income | −$21.0M | −$11.1M | −$1.0M |
| Cash | |||
| Cash from operations | −$16.5M | −$16.4M | −$19.8M |
| Capital expenditure | $0.1M | $0.2M | $0.1M |
| Free cash flow | −$16.6M | −$16.7M | −$19.8M |
| Debt and strength | |||
| Cash and short-term investments | $5.4M | $2.9M | $12.6M |
| Shareholders' equity | −$26.8M | −$32.9M | −$32.2M |
| Current ratio | 2.3x | 2.6x | 1.5x |
| Returns and quality | |||
| Altman Z'' | −54.0 | −37.8 | −52.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
BeyondSpring Inc. · BYSI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.46 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0001677940). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.